Rugby Chest Congestion Relief Tablet
NDC Package 0536-1309-08
Package Information
Rugby Chest Congestion Relief (guaifenesin/phenylephrine) tablets is ■ adults and children 12 years and over:take 1 caplet every 4 hours as needed■ children 6 to under 12 years:take 1/2 caplet every 4 hours as needed■ children under 6 years: consult a doctorDo not exceed 6 doses in a 24 hour period or as directed by a doctor. This formulation utilizes a tablet delivery system. Marketed by Rugby Laboratories, this product is identified by NDC 0536-1309 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1304111 - guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet
- RxCUI: 1304111 - guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 0536 - Rugby Laboratories
- 0536-1309 - Rugby Chest Congestion Relief
- 0536-1309-08 - 1 BOTTLE, PLASTIC in 1 CARTON / 60 TABLET in 1 BOTTLE, PLASTIC
- 0536-1309 - Rugby Chest Congestion Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0536-1309). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0536-1309-08 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 60 tablet in 1 bottle, plastic of Rugby Chest Congestion Relief PE, a human over the counter drug labeled by Rugby Laboratories. This tablet is formulated for oral use and contains guaifenesin; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Rugby Laboratories on September 09, 2020. The current certification is valid through December 31, 2026.
How is this Rugby Laboratories product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00536130908. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.